Exclusive: Glen Tullman's startup Transcarent is raising $125 million in new funding at a $2.1 billion valuation [Business Insider]
Teladoc Health, Inc. (TDOC)
Last teladoc health, inc. earnings: 4/29 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.teladoc.com/investors/default.aspx
Company Research
Source: Business Insider
The deal includes structured terms meant to protect investors against Transcarent's hefty losses. Livongo veteran Glen Tullman's latest venture, healthcare startup Trascarent, is raising a Series D round, Business Insider has learned. Transcarent, which connects employers with a suite of medical services, is targeting a $125 million raise led by General Catalyst, according to two people with knowledge of the efforts. The sources said the round values Transcarent at about $2.1 billion. It's been a difficult fundraising environment for growth-stage healthcare startups — and that's reflected in Transcarent's latest fundraising push. The two people said the deal includes liquidation preference, which is meant to protect investors in the face of risk, including a stipulation that investors will get paid back 2.5 times the amount they put in the event of an exit or IPO. The round hasn't yet closed and terms of the deal could change. In a statement to BI, Transcarent vice presiden
Show less
Read more
Impact Snapshot
Event Time:
TDOC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TDOC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TDOC alerts
High impacting Teladoc Health, Inc. news events
Weekly update
A roundup of the hottest topics
TDOC
News
- Why Teladoc Health Stock Dived on Friday [Yahoo! Finance]Yahoo! Finance
- Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $26.00 to $21.00. They now have an "outperform" rating on the stock.MarketBeat
- Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Royal Bank of Canada from $25.00 to $18.00. They now have an "outperform" rating on the stock.MarketBeat
- Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Evercore ISI from $15.00 to $14.00. They now have an "in-line" rating on the stock.MarketBeat
- Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at TD Cowen from $16.00 to $15.00. They now have a "hold" rating on the stock.MarketBeat
TDOC
Earnings
- 4/25/24 - Miss
TDOC
Sec Filings
- 4/26/24 - Form 10-Q
- 4/25/24 - Form 8-K
- 4/19/24 - Form 144
- TDOC's page on the SEC website